Launch of the EUCCC Position Paper 2013/2014

The European Chamber’s highly-anticipated and influential annual Position Paper was  launched on 5 September in the Fours Season’s Hotel. I attended the morning Press Conference as Chair of the Public Procurement Working Group.
This year’s paper includes 26 vertical industry working group papers with more than 800 recommendations. It draws directly from the knowledge and expertise of the Chamber’s 1,700 member companies following a six-month consultative process.
European Chamber President Davide Cucino introduced the Position Paper at a press conference attended by more than 100 members of the media. He then provided an overview of the Executive Position Paper — which highlights many of the main issues raised in the working group papers — illustrating his points with clear examples and proposing constructive recommendations to promote China’s sustainable economic growth. The pillars of the Executive Position Paper are as follows:

  • Strike a new balance between market forces and government control through strengthening the Chinese Government’s role as regulator while reducing the role of government in terms of its control over the financial system, implementation of industrial policies and the role it gives to SOEs.
  • Reassess the Chinese Government’s approach to technology and innovation and the top-down approach to guiding technology choices that, contrary to intentions, serve to distort markets and prevent China from creating an innovative society.
  • Bring China’s investment environment closer to international norms and increase levels of openness to foreign investment by integrating international practices into domestic policies through better engagement with, and leadership in, international standards and regulatory bodies.

For a more detailed summary of the Executive Position Paper, read more at EURObiz Online:
http://www.eurobiz.com.cn/european-chamber-position-paper/


Pictures by Gilbert, text by the EUCCC.
See also Bruno Gensburger, the chair of the Pharmaceutical Working Group, being interviewed by the media (not difficult to guess what was the subject, or?)